BIAF
bioAffinity Technologies, Inc. (BIAF) Economic Moat Analysis (2026)
No material changes this month.
Intangible Assets
BIAF does not show evidence of durable brand, patent, or regulatory-intangible advantages in the provided filings-linked metrics, so it lacks the pricing power seen in stronger peer moats.
Negative TTM ROIC and ROCE indicate that any proprietary assets are not translating into superior returns versus peers, which weakens evidence of monetizable intangibles.
With no disclosed long-run margin or growth evidence in the supplied data, there is no basis to infer persistent customer preference or protected demand relative to peers.
Switching Costs
The provided metrics do not indicate embedded workflows, contractual lock-in, or high renewal dependence, so customer retention appears weak versus peers with stronger switching frictions.
Negative ROIC suggests customers are not paying for a differentiated, hard-to-replace solution that sustains excess returns over time.
No evidence in the supplied data supports recurring usage, integration depth, or compliance dependence that would raise switching costs above peer levels.
Network Effects
The supplied information contains no evidence of user-to-user, data, or ecosystem feedback loops, so there is no visible network effect advantage versus peers.
Negative capital returns imply the business is not yet converting scale into a self-reinforcing adoption loop that would strengthen retention or pricing power.
Absent platform-like metrics or peer dependency, network effects appear immaterial to moat durability.
Cost Advantage
TTM ROIC and ROCE are both negative, which argues against a structural cost advantage because the company is not generating excess returns from its operating model.
Asset turnover is modest rather than exceptional, so the available efficiency signal does not show a clear operating-cost edge versus peers.
The provided data do not show scale-driven unit cost compression or procurement leverage that would support durable margin superiority.
Efficient Scale
The available metrics do not indicate a concentrated niche with natural monopoly economics, so efficient-scale protection appears limited versus peers.
Negative returns on invested capital suggest the business is not benefiting from a scarce-market structure that would allow incumbency to sustain returns.
No evidence of regulated exclusivity, capacity constraints, or dominant local share is present in the supplied data to support efficient-scale durability.
Overall Score
BIAF shows no observable durable moat in the provided data, as negative capital returns and the absence of evidence for intangibles, switching costs, network effects, cost advantage, or efficient scale point to weak peer-relative pricing power and retention.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on bioAffinity Technologies, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
